Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study)

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 5, 2007, Pages 602-610

  Henriksen, Magne ^a,f   Jahnsen, Jørgen ^b   Lygren, Idar ^c   Aadland, Erling ^b   Schulz, Tom ^d   Vatn, Morten H ^e   Moum, Bjørn ^b   Aubert, Erik ^a   Stray, Njål ^g   Sauar, Jostein ^h   Flaaten, Borgar ⁱ   Kjellevold, Øystein ^j  

^a Østfold Hospital Moss   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d Aust Agder Central Hospital   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f Østfold Central Hospital Moss   (Norway)

^g DIAKONHJEMMET HOSPITAL   (Norway)

^h TELEMARK HOSPITAL   (Norway)

ⁱ Notodden Hospital   (Norway)

^j Blefjell sykehus HF   (Norway)

more..

Author keywords

Crohn's disease; Follow up; Inflammatory bowel disease; Prognosis; Vienna classification

Indexed keywords

AMINOSALICYLIC ACID; GLUCOCORTICOID; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; COLONOSCOPY; COURSE EVALUATION; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SCHOOL CHILD; STRUCTURED INTERVIEW; SURGICAL RISK;

EID: 34247368044     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520601076124     Document Type: Article

References (26)

1. Silverstein MD, Loftus EV, Sandborn WJ, Tremaine WJ, Feagan BG, Nietert PJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 1999;117:49-57.
2. Zankel E, Rogler G, Andus T, Reng CM, Scholmerich J, Timmer A. Crohn's disease patient characteristics in a tertiary referral center: comparison with patients from a population-based cohort. Eur J Gastroenterol Hepatol 2005;17:395-401.
3. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; Suppl 170:2-6; discussion 16-19.
4. Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 1975;68(4 Pt 1):627-35.
5. Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, et al. Perforating and nonperforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988;29:588-92.
6. Sacher DB, Anrews HA, Farmer RG, Pallone F, Pena AS, Prantera C, et al. Proposed classification of patients subgroups in Crohn's disease. Gastroenterology Int 1992;5: 141-5.
7. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
8. Wolters FL, Russel MG, Stockbrugger RW. Systematic review: has disease outcome in Crohn's disease changed during the last four decades? Aliment Pharmacol Ther 2004;20:483-96.
9. Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol 1997;32:1005-12.
10. Moum B, Vatn MH, Ekbom A, Fausa O, Aadland E, Lygren I, et al. Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists. Digestion 1995;56:377-81.
11. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49:777-82.
12. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000; 231:38-45.
13. Veloso FT, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 2001;7:306-13.
14. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993;105:1716-23.
15. Freeman HJ. Natural history and clinical behavior of Crohn's disease extending beyond two decades. J Clin Gastroenterol 2003;37:216-9.
16. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-50.
17. Nos P, Garrigues V, Bastida G, Maroto N, Ponce M, Ponce J. Outcome of patients with nonstenotic, nonfistulizing Crohn's disease. Dig Dis Sci 2004;49:1771-6.
18. Agrez MV, Valente RM, Pierce W, Melton LJ 3rd, van Heerden JA, Beart RW Jr. Surgical history of Crohn's disease in a well-defined population. Mayo Clin Proc 1982;57:747-52.
19. Sandborn WJ, Feagan BG. Review article: mild to moderate Crohn's disease - defining the basis for a new treatment algorithm. Aliment Pharmacol Ther 2003;18:263-77.
20. Akobeng AK, Gardener E. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease. Cochrane Database of Systematic Reviews (Online: Update Software) 2005;(1)(1):CD003715.
21. Hanauer SB, Stromberg U. Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol 2004;2:379-88.
22. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001;121:255-60.
23. Munkholm P, Langholz E, Davidsen M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994;35:360-2.
24. Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995;30:699-706.
25. Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002;97:389-96.
26. Minderhoud IM, Oldenburg B, Wismeijer JA, van Berge Henegouwen GP, Smout AJ. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004;4:469-74.